(Q37082123)

18 August 2017

Association between serious ischemic cardiac outcomes and medications used to treat diabetes (English)

1 reference

18 August 2017

David J Margolis

1

1 reference

PMCID

2635115

18 August 2017

Ole Hoffstad

series ordinal

2

1 reference

PMCID

2635115

18 August 2017

Brian L Strom

series ordinal

3

1 reference

18 August 2017

1 August 2008

1 reference

Pharmacoepidemiology and Drug Safety

18 August 2017

1 reference

18 August 2017

17

1 reference

18 August 2017

8

1 reference

18 August 2017

753-759

1 reference

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Rosiglitazone and cardiovascular risk.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635115

Cardiac safety of diabetes therapies and postmarketing requirements

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPDS.1630

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

21 January 2018

1 reference

12 December 2020

Chronic kidney disease in adults--UK guidelines for identification, management and referral

1 reference

12 December 2020

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

12 December 2020

Prevalence of cardiovascular risk factors in patients with psoriasis

1 reference

12 December 2020

Coronary heart disease outcomes in patients receiving antidiabetic agents

1 reference

12 December 2020

The rosiglitazone story--lessons from an FDA Advisory Committee meeting

1 reference

12 December 2020

Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4)

1 reference

12 December 2020

Identifiers

DOI

10.1002/PDS.1630

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

2635115